Literature DB >> 27323320

Epilepsy and cataplexy in Angelman syndrome. Genotype-phenotype correlations.

Line Granild Bie Mertz1, Rikke Christensen2, Ida Vogel2, Jens Michael Hertz3, John R Østergaard4.   

Abstract

BACKGROUND: Angelman syndrome (AS) is a neurogenetic disorder characterized by intellectual disability, epilepsy, and low threshold for laughter. AIMS: We investigated the occurrence and severity of epilepsy and laughter-induced loss of postural muscle tone determined by the different genetic subtypes.
METHODS: This study included 39 children with AS. Deletion breakpoints were determined by high resolution CGH microarray (1×1M Agilent). Clinical data were based on a parent interview and medical record review.
RESULTS: All patients with AS based on a deletion had epilepsy. Epilepsy was present in 3/4 children with UBE3A mutation, and 4/5 with pUPD. Onset of epilepsy occurred earlier in deletion cases compared to pUPD or UBE3A mutations cases. Laughter-induced postural muscle tone loss occurred only among deletion cases. We found no differences in severity of epilepsy between children with a larger Class I or a smaller Class II deletions, or between the total group with a deletion compared to children with pUPD or a UBE3A mutation. The drugs most frequently prescribed were benzodiazepines in monotherapy, or a combination of benzodiazepines and valproic acid.
CONCLUSION: Epilepsy is very common in patients with AS, especially in patients with a deletion. Postural muscle tone loss and collapsing during outbursts of laughter were seen in patients with a deletion only.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  15q11.2–q13; Angelman syndrome; Cataplexy; Epilepsy; Seizures

Mesh:

Substances:

Year:  2016        PMID: 27323320     DOI: 10.1016/j.ridd.2016.06.002

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  3 in total

Review 1.  Cataplexy and Its Mimics: Clinical Recognition and Management.

Authors:  Sigrid Pillen; Fabio Pizza; Karlien Dhondt; Thomas E Scammell; Sebastiaan Overeem
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

2.  Clinical Characterization of Epilepsy in Children With Angelman Syndrome.

Authors:  Daiana Cassater; Mariana Bustamante; Lisa Sach-Peltason; Alexander Rotenberg; Mark Nespeca; Wen-Hann Tan; Lynne M Bird; Joerg F Hipp
Journal:  Pediatr Neurol       Date:  2021-08-31       Impact factor: 3.372

3.  An overview of health issues and development in a large clinical cohort of children with Angelman syndrome.

Authors:  Karen G C B Bindels-de Heus; Sabine E Mous; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Cindy Navis; André B Rietman; Leontine W Ten Hoopen; Alice S Brooks; Ype Elgersma; Henriëtte A Moll; Marie-Claire Y de Wit
Journal:  Am J Med Genet A       Date:  2019-11-15       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.